Davis Andrew S.'s Form 4 filing
Silk Road Medical Inc (SILK) · filed Oct 5, 2021
- Accession no.
- 0001593968-21-002243
- Filed
- Oct 5, 2021
- Trade date
- Oct 1, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $340.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Andrew S.CIK 0001770191 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Common Stock | MOption exerciseAcquired | +3,773 | $4.73 | +$17,846.29 | 74,028 | Direct | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −3,773 | $53.90F2 | −$203,364.7 | 70,255 | Direct | |
| Oct 1, 2021 | Common Stock | MOption exerciseAcquired | +2,551 | $4.73 | +$12,066.23 | 72,806 | Direct | |
| Oct 1, 2021 | Common Stock | SSaleDisposed | −2,551 | $53.90F2 | −$137,498.9 | 70,255 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2021 | Common Stock | MOption exerciseDisposed | −3,773 | $0.00 | $0 | 63,196 | Direct | |
| Oct 1, 2021 | Common Stock | MOption exerciseDisposed | −2,551 | $0.00 | $0 | 27,405 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at price ranging from $52.94 to $54.63. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 2 transactions in Table I.